Can-Fite BioPharma Ltd. (CANF) short interest & options flow
TASECan-Fite BioPharma heads into the week with short sellers in full retreat — a dramatic reversal from a peak that coincided almost exactly with its most important clinical readout in years. The positioning story over the past fortnight has been striking. Short interest climbed from under 0.5% of the free float in late April to a peak of nearly 13% on May 5 — a 25-fold increase in…
- Market cap
- $5M
- Next earnings
- 27 Nov 2026
Key data as of 12 Nov 2026

CANF news and analysis
RSSNo long-form analysis yet for CANF. Pulse alerts and the live data picture are available on ORTEX.
Open CANF on ORTEX →Want the live picture for CANF?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CANF — free to start on ORTEX.
Sign up for free →Open CANF on ORTEX